These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 26215128)

  • 1. Effectiveness of hyperbaric oxygen for experimental treatment of schistosomiasis mansoni using praziquantel-free and encapsulated into liposomes: assay in adult worms and oviposition.
    Frezza TF; de Souza AL; Prado CC; de Oliveira CN; Gremião MP; Giorgio S; Dolder MA; Joazeiro PP; Allegretti SM
    Acta Trop; 2015 Oct; 150():182-9. PubMed ID: 26215128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomal-praziquantel: efficacy against Schistosoma mansoni in a preclinical assay.
    Frezza TF; Gremião MP; Zanotti-Magalhães EM; Magalhães LA; de Souza AL; Allegretti SM
    Acta Trop; 2013 Oct; 128(1):70-5. PubMed ID: 23811113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of two praziquantel treatments among primary school children in an area of high Schistosoma mansoni endemicity, Nile Delta, Egypt.
    Barakat R; El Morshedy H
    Parasitology; 2011 Apr; 138(4):440-6. PubMed ID: 21078223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the antischistosomal effect of levo- and dextro-praziquantel on Schistosoma japonicum and S. mansoni in mice.
    Tanaka M; Ohmae H; Utsunomiya H; Nara T; Irie Y; Yasuraoka K
    Am J Trop Med Hyg; 1989 Aug; 41(2):198-203. PubMed ID: 2505624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anthelmintic activity in vitro and in vivo of Baccharis trimera (Less) DC against immature and adult worms of Schistosoma mansoni.
    de Oliveira RN; Rehder VL; Oliveira AS; Jeraldo Vde L; Linhares AX; Allegretti SM
    Exp Parasitol; 2014 Apr; 139():63-72. PubMed ID: 24602876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a method for induction of praziquantel resistance in Schistosoma mansoni.
    Lotfy WM; Hishmat MG; El Nashar AS; Abu El Einin HM
    Pharm Biol; 2015 Aug; 53(8):1214-9. PubMed ID: 25609146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of praziquantel on the eggs of Schistosoma mansoni, with a note on the implications for managing central nervous system schistosomiasis.
    Richards F; Sullivan J; Ruiz-Tiben E; Eberhard M; Bishop H
    Ann Trop Med Parasitol; 1989 Oct; 83(5):465-72. PubMed ID: 2515814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schistosoma mansoni: In vivo evaluation of Phyllanthus amarus hexanic and ethanolic extracts.
    de Oliveira CNF; Frezza TF; Garcia VL; Figueira GM; Mendes TMF; Allegretti SM
    Exp Parasitol; 2017 Dec; 183():56-63. PubMed ID: 29074138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of prophylactic efficacy and safety of praziquantel-miltefosine nanocombination in experimental Schistosomiasis mansoni.
    Eissa MM; El-Azzouni MZ; El-Khordagui LK; Abdel Bary A; El-Moslemany RM; Abdel Salam SA
    Acta Trop; 2020 Dec; 212():105714. PubMed ID: 32950482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parasitological, hematological and ultrastructural study of the effect of COX-2 inhibitor, pyocyanin pigment and praziquantel, on S. mansoni infected mice.
    Mohamed AH; Ezz El-Din N; Fahmy ZH; El-Shennawy AM; Hassan E
    J Egypt Soc Parasitol; 2006 Apr; 36(1):197-220. PubMed ID: 16605111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult worm tegumental damage and egg-granulomas in praziquantel-resistant and -susceptible Schistosoma mansoni treated in vivo.
    Liang YS; Coles GC; Dai JR; Zhu YC; Doenhoff MJ
    J Helminthol; 2002 Dec; 76(4):327-33. PubMed ID: 12498638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of the therapeutic efficacy of praziquantel in murine Schistosomiasis mansoni using silica nanocarrier.
    Tawfeek GM; Baki MHA; Ibrahim AN; Mostafa MAH; Fathy MM; Diab MSEDM
    Parasitol Res; 2019 Dec; 118(12):3519-3533. PubMed ID: 31673833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo assessment of the antischistosomal activity of curcumin loaded nanoparticles versus praziquantel in the treatment of Schistosoma mansoni.
    Mokbel KEM; Baiuomy IR; Sabry AEA; Mohammed MM; El-Dardiry MA
    Sci Rep; 2020 Sep; 10(1):15742. PubMed ID: 32978497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population Pharmacokinetics and Pharmacodynamics of Praziquantel in Ugandan Children with Intestinal Schistosomiasis: Higher Dosages Are Required for Maximal Efficacy.
    Bustinduy AL; Waterhouse D; de Sousa-Figueiredo JC; Roberts SA; Atuhaire A; Van Dam GJ; Corstjens PL; Scott JT; Stanton MC; Kabatereine NB; Ward S; Hope WW; Stothard JR
    mBio; 2016 Aug; 7(4):. PubMed ID: 27507822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Praziquantel in a clay nanoformulation shows more bioavailability and higher efficacy against murine Schistosoma mansoni infection.
    El-Feky GS; Mohamed WS; Nasr HE; El-Lakkany NM; Seif El-Din SH; Botros SS
    Antimicrob Agents Chemother; 2015; 59(6):3501-8. PubMed ID: 25845870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effect of subcurative dose praziquantel on Schistosoma mansoni infected mice and resistance to challenge infection after treatment.
    Chaiworaporn R; Maneerat Y; Rojekittikhun W; Ramasoota P; Janecharut T; Matsuda H; Kitikoon V
    Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):846-52. PubMed ID: 16295535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy and bioavailability of different praziquantel brands.
    Botros S; El-Lakkany N; Seif el-Din SH; Sabra AN; Ibrahim M
    Exp Parasitol; 2011 Feb; 127(2):515-21. PubMed ID: 21044626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the pharmacokinetic-pharmacodynamic relationship of praziquantel in the Schistosoma mansoni mouse model.
    Abla N; Keiser J; Vargas M; Reimers N; Haas H; Spangenberg T
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005942. PubMed ID: 28934207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antischistosomal effects of praziquantel, its alkaline hydrolysis and sun decomposed products on experimentally S. mansoni infected albino mice. (A) Efficacy assessment based on clinicopathological findings.
    Suleiman MI; Akarim EI; Ibrahim KE; Saad AM; Mohammed AE; Ahmed BM; Sulaiman SM
    J Egypt Soc Parasitol; 2004 Apr; 34(1):131-42. PubMed ID: 15143740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The phosphodiesterase-4 inhibitor roflumilast impacts Schistosoma mansoni ovipositing in vitro but displays only modest antischistosomal activity in vivo.
    Botros SS; El-Lakkany NM; Seif El-Din SH; William S; Sabra AN; Hammam OA; de Koning HP
    Exp Parasitol; 2020 Jan; 208():107793. PubMed ID: 31711973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.